Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 July 2019 | Story Valentino Ndaba
Prof Dave Lubbe
Winner of the Southern African Accounting Association Lifetime Achievement Award, Prof Dave Lubbe, has lived a life full of achievements.

The highest body of professional academic accountants in the country, the Southern African Accounting Association (SAAA), recently honoured Prof Dave Lubbe with the prestigious Lifetime Achievement Award at a gala dinner at Emperors Palace in Johannesburg. Prof Lubbe is a Research Associate and an Emeritus Professor at the School of Accountancy at the University of the Free State (UFS).

The SAAA honoured him “for his distinguished service and valuable contribution to accounting education in South Africa”. He was recognised for his contributions to audit committees in the private and public sectors, environmental accounting and auditing, the philosophy of auditing, audit risk and the expectation gap between the audit profession and users of financial information. 
     
A friend of firsts

Prof Lubbe was the first person to attain a doctorate in Auditing in South Africa, the first to author an Afrikaans auditing handbook, the first South African recipient of the Ernst & Young Outstanding Accounting Research Award in 2002 and the first Chartered Accountant to be awarded the Stals Prize for Economic and Management Sciences by the South African Academy for Science and Arts in 2007.  

His astounding track record also earned him the university’s 2018 Executive Management Award at the 36th Chancellor’s Distinguished Alumni Awards. Not only is he a former master’s student at the university, but he also went on to serve as a senior lecturer for 41 years.

Called to serve

In his lifetime, Prof Lubbe has answered the call to serve as a management consultant, committee member, a forensic accountant, and an assessor to high court fraud cases. 

Beyond the field of accounting
 

His achievements span beyond the accounting field. Not only has Prof Lubbe completed all of South Africa’s well-known ultramarathons, he holds a black belt in karate. His love for art on the other hand, has seen him win national poetry competitions and establishing himself as a lyricist.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept